دواعي استعمال رينجر اسيتات النصر محلول وريدي 500 مل

Ringer's acetate solution for intravenous infusion, 500 ml, used for fluid and electrolyte replacement.

• تعويض فقد السوائل خارج الخلوية والإلكتروليتات أو تعويض الحجم قصير المدىالفئة: Adults and childrenSwedish Medical Products Agency (Lakemedelsverket) product document

• Hypersensitivity/anaphylactoid reactions and urticaria (frequency not known).نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Hyponatremia, overhydration, electrolyte disturbances, hyponatremic encephalopathy (frequency not known).نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Common: heart failure in patients with cardiac disorders, pulmonary edema, febrile reaction, injection site infection, pain, vein irritation, thrombosis or phlebitis, extravasation.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document

• فرط الحساسية للمستحضر أو مكوناته.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• فرط الترطيب خارج الخلوي أو فرط حجم الدم.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Concomitant ceftriaxone in preterm and term newborns (28 days or younger), even with separate lines.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document

• Ceftriaxone must not be mixed or given simultaneously with calcium-containing IV solutions at any age.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• High-volume infusion needs specific monitoring in cardiac or pulmonary failure, edema, ascitic cirrhosis or renal insufficiency.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Risk of acute hyponatremia and hyponatremic encephalopathy, especially in children and patients with non-osmotic vasopressin release; monitor fluid balance and electrolytes.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Caution with potassium in cardiac disease or hyperkalemia-prone conditions; not suitable to correct severe hypokalemia.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Calcium: caution in hypercalcemia, renal impairment, sarcoidosis, calcium renal calculi, digitalis therapy; do not give through the same set as blood transfusion.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Acetate may cause metabolic alkalosis; not suitable for treating severe metabolic or respiratory acidosis.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document

• CeftriaxoneContraindicated in neonates; never mixed or given simultaneously at any age.Swedish Medical Products Agency (Lakemedelsverket) product document
• Drugs lowering serum sodium (diuretics, NSAIDs, antipsychotics, SSRIs, opioids, antiepileptics, oxytocin, chemotherapy)Increased risk of hyponatremia.Swedish Medical Products Agency (Lakemedelsverket) product document
• SuxamethoniumWith potassium may cause considerable hyperkalemia.Swedish Medical Products Agency (Lakemedelsverket) product document
• Corticosteroids, potassium-sparing diuretics, ACE inhibitors, ARBs, tacrolimus, ciclosporinPotassium and/or sodium retention.Swedish Medical Products Agency (Lakemedelsverket) product document
• Digitalis glycosidesCalcium increases risk of digitalis toxicity.Swedish Medical Products Agency (Lakemedelsverket) product document
• Salicylates, lithium, barbiturates / quinidine, sympathomimeticsUrinary alkalinization from acetate increases elimination of acidic drugs and decreases elimination of quinidine and sympathomimetics.Swedish Medical Products Agency (Lakemedelsverket) product document
• Thiazide diuretics, vitamin DIncreased risk of hypercalcemia.Swedish Medical Products Agency (Lakemedelsverket) product document

• Can be used during pregnancy; during labour, especially with oxytocin, there may be an increased risk of hyponatremia.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document
• Can be used during lactation.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document

• Monitor fluid balance, blood and urine electrolytes and acid-base balance before and during administration.نشرة دولية لتركيبة مكافئة · Swedish Medical Products Agency (Lakemedelsverket) product document